Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$878,978
+$121,026 QoQ
Shares Held
3,493
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#2,675
of 4,167 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sage Capital Management, LLC holds $2,235,834 across 3 Drug Manufacturers - General names. ABBV ranks #1 (39.3% of the industry book) .
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $878,978 | 3,493 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $757,952 | 3,485 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $794,459 | 3,477 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $803,675 | 3,471 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $642,987 | 3,464 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $723,891 | 3,455 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $612,531 | 3,447 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $669,259 | 3,389 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $580,080 | 3,382 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $614,223 | 3,373 | Shares | Sole | 2024-07-31 | |
| 2023-12-31 | $521,629 | 3,366 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||